rs7076862

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_001033855.3(DCLRE1C):​c.643C>T​(p.Leu215Leu) variant causes a synonymous change. The variant allele was found at a frequency of 0.394 in 1,613,398 control chromosomes in the GnomAD database, including 131,213 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 16737 hom., cov: 30)
Exomes 𝑓: 0.39 ( 114476 hom. )

Consequence

DCLRE1C
NM_001033855.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11O:1

Conservation

PhyloP100: 3.65

Publications

20 publications found
Variant links:
Genes affected
DCLRE1C (HGNC:17642): (DNA cross-link repair 1C) This gene encodes a nuclear protein that is involved in V(D)J recombination and DNA repair. The encoded protein has single-strand-specific 5'-3' exonuclease activity; it also exhibits endonuclease activity on 5' and 3' overhangs and hairpins. The protein also functions in the regulation of the cell cycle in response to DNA damage. Mutations in this gene can cause Athabascan-type severe combined immunodeficiency (SCIDA) and Omenn syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
DCLRE1C Gene-Disease associations (from GenCC):
  • Omenn syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: G2P, Ambry Genetics, Orphanet
  • severe combined immunodeficiency due to DCLRE1C deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 10-14934415-G-A is Benign according to our data. Variant chr10-14934415-G-A is described in ClinVar as Benign. ClinVar VariationId is 36000.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.641 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DCLRE1CNM_001033855.3 linkc.643C>T p.Leu215Leu synonymous_variant Exon 8 of 14 ENST00000378278.7 NP_001029027.1 Q96SD1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DCLRE1CENST00000378278.7 linkc.643C>T p.Leu215Leu synonymous_variant Exon 8 of 14 1 NM_001033855.3 ENSP00000367527.2 Q96SD1-1

Frequencies

GnomAD3 genomes
AF:
0.451
AC:
68424
AN:
151738
Hom.:
16692
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.646
Gnomad AMI
AF:
0.445
Gnomad AMR
AF:
0.441
Gnomad ASJ
AF:
0.432
Gnomad EAS
AF:
0.417
Gnomad SAS
AF:
0.544
Gnomad FIN
AF:
0.265
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.360
Gnomad OTH
AF:
0.446
GnomAD2 exomes
AF:
0.416
AC:
104558
AN:
251182
AF XY:
0.416
show subpopulations
Gnomad AFR exome
AF:
0.655
Gnomad AMR exome
AF:
0.477
Gnomad ASJ exome
AF:
0.428
Gnomad EAS exome
AF:
0.409
Gnomad FIN exome
AF:
0.262
Gnomad NFE exome
AF:
0.358
Gnomad OTH exome
AF:
0.392
GnomAD4 exome
AF:
0.388
AC:
567459
AN:
1461544
Hom.:
114476
Cov.:
61
AF XY:
0.393
AC XY:
285397
AN XY:
727062
show subpopulations
African (AFR)
AF:
0.663
AC:
22188
AN:
33448
American (AMR)
AF:
0.472
AC:
21097
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.436
AC:
11382
AN:
26130
East Asian (EAS)
AF:
0.471
AC:
18696
AN:
39698
South Asian (SAS)
AF:
0.550
AC:
47403
AN:
86188
European-Finnish (FIN)
AF:
0.262
AC:
14010
AN:
53410
Middle Eastern (MID)
AF:
0.462
AC:
2664
AN:
5768
European-Non Finnish (NFE)
AF:
0.365
AC:
405588
AN:
1111848
Other (OTH)
AF:
0.405
AC:
24431
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.435
Heterozygous variant carriers
0
20392
40783
61175
81566
101958
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13234
26468
39702
52936
66170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.451
AC:
68536
AN:
151854
Hom.:
16737
Cov.:
30
AF XY:
0.450
AC XY:
33393
AN XY:
74214
show subpopulations
African (AFR)
AF:
0.647
AC:
26770
AN:
41376
American (AMR)
AF:
0.442
AC:
6740
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.432
AC:
1495
AN:
3462
East Asian (EAS)
AF:
0.419
AC:
2167
AN:
5178
South Asian (SAS)
AF:
0.543
AC:
2612
AN:
4806
European-Finnish (FIN)
AF:
0.265
AC:
2787
AN:
10534
Middle Eastern (MID)
AF:
0.507
AC:
148
AN:
292
European-Non Finnish (NFE)
AF:
0.360
AC:
24479
AN:
67934
Other (OTH)
AF:
0.444
AC:
932
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1793
3585
5378
7170
8963
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
624
1248
1872
2496
3120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.384
Hom.:
4954
Bravo
AF:
0.472
Asia WGS
AF:
0.454
AC:
1579
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 65% of patients studied by a panel of primary immunodeficiencies. Number of patients: 57. Only high quality variants are reported. -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Histiocytic medullary reticulosis Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Severe combined immunodeficiency due to DCLRE1C deficiency Benign:2
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Severe combined immunodeficiency disease Benign:1
Aug 18, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing;curation

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
5.6
DANN
Benign
0.78
PhyloP100
3.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7076862; hg19: chr10-14976414; COSMIC: COSV63182212; COSMIC: COSV63182212; API